- Your cart is empty
- Continue Shopping
Product
Letromina – Anti-Estrogen Drugs
$33.91 Sales Tax
Add to cart
Buy Now
Description
Letromina
Specification
| Common | |
| Active substance | Letrozole Citrate |
| Indications | Letromina is indicated in treatment of breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy or as initial treatment of hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer |
| Dosage | |
| Quantity | |
| Unit | |
| Time | |
| Potency | |
| Quantity | 2,5 |
| Unit | Milligram |
| Packaging | |
| Quantity | 30 |
| Unit | Tablet |
| Type | Carton |
| Presentation | Each carton contains 30 tablets of 2.5mg each |
Related products
